What is the differential diagnosis and recommended workup for a patient with a slightly elevated 17‑hydroxyprogesterone level and mildly elevated testosterone?

Differential Diagnosis and Workup for Slightly Elevated 17-OHP (56 ng/dL) and Mildly Elevated Testosterone

Perform an ACTH stimulation test with a complete adrenocortical profile to differentiate between non-classic congenital adrenal hyperplasia (NCCAH), polycystic ovary syndrome (PCOS), and other causes of hyperandrogenism. 1

Differential Diagnosis

Your patient's 17-OHP level of 56 ng/dL (approximately 1.7 ng/mL) falls in the borderline range that requires further evaluation. The key differential diagnoses include:

• Non-classic congenital adrenal hyperplasia (NCCAH) due to 21-hydroxylase deficiency
• Polycystic ovary syndrome (PCOS) - the most common cause, accounting for 75% of hyperandrogenic cases 2
• Idiopathic hyperandrogenism
• Rare: 17-OHP-secreting adrenal adenoma (if imaging shows adrenal mass) 3

Algorithmic Workup Approach

Step 1: Exclude Common Endocrinopathies First

Before proceeding with ACTH stimulation, measure 2:

• TSH (exclude thyroid disease)
• Prolactin (exclude hyperprolactinemia)
• Early morning 17-OHP if not already done at optimal timing

Step 2: ACTH Stimulation Test - The Definitive Diagnostic Tool

This is mandatory for your patient. The Endocrine Society guidelines recommend obtaining a complete adrenocortical profile after cosyntropin stimulation to differentiate 21-hydroxylase deficiency from other enzyme defects 1.

Interpretation of stimulated 17-OHP levels 1:

• >300 nmol/L (>10,000 ng/dL): Classic CAH
• 31-300 nmol/L (1,000-10,000 ng/dL): Likely NCCAH
• <50 nmol/L (<1,666 ng/dL): Unaffected or heterozygote carrier

Step 3: Additional Steroid Measurements

During the ACTH stimulation test, measure 1:

• Androstenedione
• Testosterone (already elevated in your patient)
• 21-deoxycortisol (elevated in 21-hydroxylase deficiency)
• Cortisol (to assess adrenal reserve)
• DHEAS (helps differentiate PCOS from NCCAH) 4

Key distinguishing feature: DHEAS tends to be lower in NCCAH than in PCOS 4, though this is not definitive.

Step 4: Clinical Context Matters

Assess for 2, 5:

• Menstrual irregularity: Present in both PCOS and NCCAH, not discriminatory 4
• Hirsutism severity: Use Ferriman-Gallwey score; similar between PCOS and NCCAH 4
• Rapid onset or virilization signs: Suggests androgen-secreting tumor requiring imaging 6
• Polycystic ovarian morphology on ultrasound: Supports PCOS diagnosis 2

Step 5: When to Consider Genetic Testing

Genotyping of CYP21A2 is suggested only when 1:

• ACTH stimulation results are equivocal (stimulated 17-OHP between 1,000-3,000 ng/dL)
• For genetic counseling purposes
• When urinary steroid profiling is inconclusive 7

Critical Pitfalls to Avoid

1. Do not rely on basal 17-OHP alone: Your patient's level of 56 ng/dL (1.7 ng/mL) is in the gray zone where PCOS, NCCAH, and idiopathic hyperandrogenism overlap 4, 8. Research shows that auxiliary tests and clinical findings cannot reliably distinguish these conditions without ACTH stimulation 4.

2. Timing matters: Ensure 17-OHP is measured in the early morning during the follicular phase (days 3-5) in menstruating women to avoid false elevations 1.

3. Beware of ovarian contribution: In hyperandrogenic women, the ovary can also secrete excessive 17-OHP, which may elevate basal levels but not necessarily indicate adrenal pathology 8. The ACTH stimulation test helps isolate the adrenal contribution.

4. Consider imaging if atypical: If the patient has rapid symptom onset, signs of virilization, or stimulated 17-OHP is markedly elevated with normal genetic testing, obtain adrenal imaging to exclude a rare 17-OHP-secreting adenoma 3.

Treatment Implications

• If NCCAH is confirmed: Glucocorticoid therapy with hydrocortisone may be indicated, particularly if fertility is desired or symptoms are severe 1
• If PCOS is confirmed: Hormonal contraceptives are first-line for menstrual irregularities and hirsutism; metformin for metabolic abnormalities 2
• Do not delay symptomatic treatment: Acne and hirsutism management should not be withheld during the diagnostic workup 5

The ACTH stimulation test is the single most important next step to definitively categorize your patient's condition and guide appropriate therapy.